Michael Morse

2.4k total citations · 1 hit paper
6 papers, 1.8k citations indexed

About

Michael Morse is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Michael Morse has authored 6 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Michael Morse's work include Pancreatic and Hepatic Oncology Research (2 papers), RNA Interference and Gene Delivery (2 papers) and Cancer Genomics and Diagnostics (2 papers). Michael Morse is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), RNA Interference and Gene Delivery (2 papers) and Cancer Genomics and Diagnostics (2 papers). Michael Morse collaborates with scholars based in United States, Netherlands and India. Michael Morse's co-authors include Kert D. Sabbath, Michael Craig Miller, Gerald V. Doyle, Steven J. Cohen, Neal J. Meropol, Leon W.M.M. Terstappen, Cornelis J.A. Punt, Nicholas Iannotti, Joel Picus and Edith P. Mitchell and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and Radiotherapy and Oncology.

In The Last Decade

Michael Morse

5 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

2008 1.5k citations Steven J. Cohen, Cornelis J.A. Punt et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Morse United States	4	1.4k	833	446	372	349	6	1.8k
Kert D. Sabbath United States	12	1.9k 1.4×	1.2k 1.4×	544 1.2×	541 1.5×	234 0.7×	26	2.7k
Maria Perraki Greece	24	2.0k 1.4×	1.5k 1.8×	492 1.1×	682 1.8×	99 0.3×	49	2.4k
Dominic G. Rothwell United Kingdom	25	1.3k 0.9×	863 1.0×	1.1k 2.5×	334 0.9×	317 0.9×	63	2.3k
Emilian Racila United States	21	839 0.6×	335 0.4×	436 1.0×	318 0.9×	712 2.0×	45	2.0k
Laure Cayrefourcq France	19	1.1k 0.8×	831 1.0×	412 0.9×	285 0.8×	165 0.5×	34	1.4k
Giovanna Vona France	15	964 0.7×	633 0.8×	414 0.9×	325 0.9×	78 0.2×	20	2.0k
Shinya Neri Japan	19	1.1k 0.8×	366 0.4×	562 1.3×	525 1.4×	341 1.0×	36	1.7k
Erica L. Carpenter United States	26	1.1k 0.8×	1.1k 1.3×	1.4k 3.1×	620 1.7×	473 1.4×	100	3.0k
Francesca Salvianti Italy	25	840 0.6×	930 1.1×	610 1.4×	309 0.8×	151 0.4×	51	1.6k
Robert Szczepaniak‐Sloane United Kingdom	10	1.9k 1.4×	1.2k 1.5×	422 0.9×	755 2.0×	109 0.3×	12	2.3k

Countries citing papers authored by Michael Morse

Since Specialization

Citations

This map shows the geographic impact of Michael Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Morse more than expected).

Fields of papers citing papers by Michael Morse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Morse. The network helps show where Michael Morse may publish in the future.

Co-authorship network of co-authors of Michael Morse

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Morse. A scholar is included among the top collaborators of Michael Morse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Morse. Michael Morse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Gordon, Erlinda M., Christopher W. Szeto, Sandeep K. Reddy, et al.. (2019). Abstract 2556: Enhanced expression of human cyclin G1 (CCNG1) gene in metastatic cancer, a novel biomarker in development for CCNG1 inhibitor therapy. 2556–2556.

2.

Altomare, Ivy, Karen Russell, Hope E. Uronis, et al.. (2010). Phase II trial of bevacizumab (B) plus everolimus (E) for refractory metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 28(15_suppl). 3535–3535. 3 indexed citations

3.

Iversen, Patrick L., Katherine M. Aird, Rebecca Wu, Michael Morse, & Gayathri R. Devi. (2009). Cellular Uptake of Neutral Phosphorodiamidate Morpholino Oligomers. Current Pharmaceutical Biotechnology. 10(6). 579–588. 19 indexed citations

4.

Cohen, Steven J., Cornelis J.A. Punt, Nicholas Iannotti, et al.. (2008). Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 26(19). 3213–3221. 1473 indexed citations breakdown →

5.

Czito, Brian G., Christopher Willett, J. C. Bendell, et al.. (2006). 158 Increased toxicity with gefitinib, capecitabine and radiation in pancreatic and rectal cancer: phase I trial results. Radiotherapy and Oncology. 78. S53–S54. 1 indexed citations

6.

Nair, Smita K., David Boczkowski, Michael Morse, et al.. (1998). Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotechnology. 16(4). 364–369. 335 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact